Commission Regulation (EC) No 1609/2006 of 27 October 2006 authorising the placing on the market of infant formulae based on hydrolysates of whey protein derived from cows’ milk protein for a two-year period (Text with EEA relevance)
Grade B
mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.
Address https://gelex.eu/eli/EU/regulation/2006/1609@2006-10-27/en
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Council Directive 89/398/EEC of 3 May 1989 on the approximation of the laws of the Member States relating to foodstuffs intended for particular nutritional uses, and in particular Article 4(1a) thereof,
Having consulted the European Food Safety Authority,
Whereas:
(1) Directive 89/398/EEC concerns foodstuffs for particular nutritional uses. The specific provisions applicable to certain groups of foods for particular nutritional uses are laid down by specific Directives.
(2) Commission Directive 91/321/EEC of 14 May 1991 on infant formulae and follow-on formulae is a specific Directive adopted pursuant to Directive 89/398/EEC. Directive 91/321/EEC lays down compositional requirements for infant formulae.
(3) The Commission received a application for the placing on the market of an innovative infant formula based on hydrolysates of whey protein derived from cows’ milk with a protein content below the minimum of 0,56 g protein/100 kJ (2,25 g protein/100 kcal), as referred to in point 2.2 of Annex I to Directive 91/321/EEC.
(4) On 5 October 2005, the European Food Safety Authority delivered its opinion. That opinion stated that infant formula, based on hydrolysates of whey protein derived from cows’ milk with a protein content of 0,47 g/100 kJ (1,9 g/100 kcal), is safe and suitable for use as the sole source of nutrition of infants.
(5) Accordingly, pending the amendment of Directive 91/321/EEC, the marketing of that infant formula should be authorised for a two-year period.
(6) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
HAS ADOPTED THIS REGULATION:
Article 1
By the way of derogation from Article 2 and Article 4(1) of Directive 91/321/EEC, the placing on the market of infant formulae based on hydrolysates of cows’ milk, as set out in the Annex to this Regulation, is authorised for a two-year period from the date of adoption of this Regulation.
Article 2
This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 27 October 2006. For the Commission Markos Kyprianou Member of the Commisison
ANNEX
ANNEX Specifications for the protein source, protein processing and protein quality used in the manufacture of infant formula based on hydrolysates of whey protein derived from cows’ milk protein
(1) Protein content Protein content = nitrogen content × 6,25 Minimum Maximum 0,44 g/100 kJ 0,7 g/100 kJ (1,86 g/100 kcal) (3 g/100 kcal)
(2) Protein source Demineralised sweet whey protein derived from cows’ milk after enzymatic precipitation of caseins using chymosin, consisting of:
(2)
(a) 63 % caseino-glycomacropeptide free whey protein isolate with a minimum protein content of 95 % of dry matter and protein denaturation of less than 70 % and a maximum ash content of 3 %; and
(b) 37 % sweet whey protein concentrate with a minimum protein content of 87 % of dry matter and protein denaturation of less than 70 % and a maximum ash content of 3,5 %.
(3) Protein processing Two-stage hydrolysis process using a trypsin preparation with a heat treatment step (from 3 to 10 minutes at 80 to 100 °C) between the two hydrolysis steps.
(4) Protein quality Essential and semi-essential amino acids in breast milk as set out in Annex V to Directive 91/321/EEC.
Versions
Cited by
- Commission Regulation (EC) No 1243/2008 of 12 December 2008 amending Annexes III and VI to Directive 2006/141/EC as regards compositional requirements for certain infant formulae (Text with EEA relevance) Regulation · Grade B
Commission Regulation (EC) No 1609/2006 of 27 October 2006 authorising the placing on the market of infant formulae based on hydrolysates of whey protein derived from cows′ milk protein for a two-year period authorises the placing on the market of infant formulae based on hydrolysates of cows′ milk in accordance with specifications for the protein content, source, processing and quality set out in the Annex thereto. That authorisation expires on 27 October 2008.
- Commission Regulation (EC) No 1243/2008 of 12 December 2008 amending Annexes III and VI to Directive 2006/141/EC as regards compositional requirements for certain infant formulae (Text with EEA relevance) Regulation · Grade B
Directive 2006/141/EC provides on a permanent basis for the authorisation laid down in Regulation (EC) No 1609/2006. Annex VI to Directive 2006/141/EC set out the specifications for the protein content, protein source and protein processing for the infant formulae in question. However, the particular compositional requirements relating to the protein quality were not included in that Annex. The absence of such requirements would prevent the placing on the market of infant formulae manufactured from protein hydrolysates following the expiry of Regulation (EC) No 1609/2006.
- Commission Regulation (EC) No 1243/2008 of 12 December 2008 amending Annexes III and VI to Directive 2006/141/EC as regards compositional requirements for certain infant formulae (Text with EEA relevance) Regulation · Grade B
The missing specifications concerning protein quality, which were included in the authorisation laid down in Regulation (EC) No 1609/2006, should be added to Annex VI to Directive 2006/141/EC. That Annex should therefore be amended accordingly.